Page 230 - Read Online

Page 14 of 14 Jagpal et al. Vessel Plus 2018;2:24 I http://dx.doi.org/10.20517/2574-1209.2018.27

37. Ekberg H, Tedesco-Silva H, Demirbas A, Vitko S, Nashan B, Gurkan A, Margreiter R, Hugo C, Grinyo JM, Frei U, Vanrenterghem Y,
Daloze P, Halloran PF. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 2007; 357:2562-75.
38. Grimm M, Rinaldi M, Yonan NA, Arpesella G, Arizón Del Prado JM, Pulpón LA, Villemot JP, Frigerio M, Rodriguez Lambert JL,
Crespo-Leiro MG, Almenar L, Duveau D, Ordonez-Fernandez A, Gandjbakhch J, Maccherini M, Laufer G. Superior prevention of acute
rejection by tacrolimus vs. cyclosporine in heart transplant recipients--a large European trial. Am J Transplant 2006;6:1387-97.
39. Teebken OE, Strüber M, Harringer W, Pichlmaier MA, Haverich A. Primary immunosuppression with tacrolimus and mycophenolate
mofetil versus cyclosporine and azathioprine in hearttransplant recipients. Transplant Proc 2002;34:1265-8.
40. Depczynski B, Daly B, Campbell LV, Chisholm DJ, Keogh A. Predicting the occurrence of diabetes mellitus in recipients of heart
transplants. Diabet Med 2000;17:15-9.
41. Baran DA, Ashkar J, Galin ID, Sandler D, Segura L, Courtney MC, Correa R, Chan M, Lansman SL, Spielvogel D, Cheng J, Gass AL.
Tacrolimus and new onset diabetes mellitus: the effect of steroid weaning. Transplant Proc 2002;34:1711-2.
42. Lindholm A, Albrechtsen D, Frodin L, Tufveson G, Persson NH, Lundgren G. Ischemic heart disease--major cause of death and graft
loss after renal transplantation in Scandinavia. Transplantation 1995;60:451-7.
43. Prada-Delgado O, Estevez-Loureiro R, Paniagua-Martin MJ, Lopez-Sainz A, Crespo-Leiro MG. Prevalence and prognostic value of
cardiac allograft vasculopathy 1 year after heart transplantation according to the ISHLT recommended nomenclature. J Heart Lung
Transplant 2012;31:332-3.
44. Kato T, Chan MC, Gao SZ, Schroeder JS, Yokota M, Murohara T, Iwase M, Noda A, Hunt SA, Valantine HA. Glucose intolerance, as
reflected by hemoglobin A1c level, is associated with the incidence and severity of transplant coronary artery disease. J Am Coll Cardiol
2004;43:1034-41.
45. Laakso M. Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly West Award Lecture 2008.
Diabetes Care 2010;33:442-9.
46. Huang Y, Cai X, Mai W, Li M, Hu Y. Association between prediabetes and risk of cardiovascular disease and all cause mortality:
systematic review and meta-analysis. BMJ 2016;355:i5953.